BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30268479)

  • 1. Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression.
    Hydbring P; De Petris L; Zhang Y; Brandén E; Koyi H; Novak M; Kanter L; Hååg P; Hurley J; Tadigotla V; Zhu B; Skog J; Viktorsson K; Ekman S; Lewensohn R
    Lung Cancer; 2018 Oct; 124():45-52. PubMed ID: 30268479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
    Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
    Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
    Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions.
    Wang Y; Xu YM; Zou YQ; Lin J; Huang B; Liu J; Li J; Zhang J; Yang WM; Min QH; Li SQ; Gao QF; Sun F; Chen QG; Zhang L; Jiang YH; Deng LB; Wang XZ
    Medicine (Baltimore); 2017 Nov; 96(44):e8361. PubMed ID: 29095265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
    Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
    Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
    Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
    Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions.
    Espósito DL; Bollela VR; Feitosa AL; da Fonseca BA
    Lung; 2015 Dec; 193(6):1001-7. PubMed ID: 26407584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysis.
    Liu XQ; Tufman A; Kiefl R; Li GF; Ma QL; Huber RM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1877-1886. PubMed ID: 32141557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
    Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
    Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
    Zhang X; Bao L; Yu G; Wang H
    Front Surg; 2022; 9():1050242. PubMed ID: 36684253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
    Ak G; Tomaszek SC; Kosari F; Metintas M; Jett JR; Metintas S; Yildirim H; Dundar E; Dong J; Aubry MC; Wigle DA; Thomas CF
    Biomed Res Int; 2015; 2015():635748. PubMed ID: 25756049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
    Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
    Taylor DD; Gercel-Taylor C
    Gynecol Oncol; 2008 Jul; 110(1):13-21. PubMed ID: 18589210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of surfactant protein-A gene transcript in the cells from pleural effusion for the diagnosis of lung adenocarcinoma.
    Saitoh H; Shimura S; Fushimi T; Okayama H; Shirato K
    Am J Med; 1997 Nov; 103(5):400-4. PubMed ID: 9375708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
    Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
    BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.